<DOC>
	<DOCNO>NCT00737880</DOCNO>
	<brief_summary>Graft preservation clinical pancreas transplantation base hypothermia achieve topic cool cold situ flush use special perfusion solution design attenuate effect ischemia/reperfusion prolong cold ischemia tolerance . For pancreas transplantation , University Wisconsin ( UW ) solution commonly use perfusate . However , last year , Histidine-Tryptophan-Ketoglutarate ( HTK ) solution increasingly use abdominal organ procurement . Retrospective report publish far demonstrated safety perfusion solution . However , date , prospective study compare perfusion solution publish . Aim study prospectively evaluate early pancreas graft function clinical pancreas transplantation organ perfusion HTK vs. UW solution . The study hypothesis HTK inferior UW organ perfusion procurement clinical pancreas transplantation .</brief_summary>
	<brief_title>Histidine-Tryptophane-Ketoglutarate ( HTK ) vs University Wisconsin ( UW ) Perfusion Clinical Pancreas Transplantation</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Pancrelipase</mesh_term>
	<mesh_term>Pancreatin</mesh_term>
	<criteria>brain dead , heart beat organ donor donor age 10 50 year donor body mass index &lt; 30kg/m2 pancreas cold ischemia time &lt; 20 hour write informed consent pancreas recipient miss write consent pancreas retransplantation recipient participation another study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 2008</verification_date>
	<keyword>Pancreas Clinical , Donor</keyword>
	<keyword>Pancreas Clinical , Preservation Solutions</keyword>
	<keyword>Organ Preservation Procurement , Surgery</keyword>
	<keyword>Organ Procurement , Ischemia reperfusion Injury</keyword>
	<keyword>Organ Preservation Procurement</keyword>
</DOC>